<DOC>
	<DOCNO>NCT00743977</DOCNO>
	<brief_summary>The present study aim compare pharmacokinetics original formulation phenazopyridine generic product .</brief_summary>
	<brief_title>Bioequivalence Phenazopyridine HCl Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy subject age 18 55 ( Male &amp; Female ) Physically mentally healthy subject confirm interview , medical history , clinical examination , laboratory test Informed consent sign subject The subject cooperative available entire study Not pregnant nursing Normal renal hepatic function Evidence subject medical history medical examination clinically significant hepatic , renal , gastrointestinal , cardiovascular , pulmonary , hematological significant acute chronic abnormality might influence either safety subject absorption , distribution , metabolism excretion active agent investigation Hypersensitivity subject drug , atopic eczema allergic bronchial asthma Evidence hypertension ( blood pressure 3 minute sit &gt; 160/95 mm Hg ) Evidence chronic acute infectious disease ; History evidence malignant tumor ; Evidence hyperuricaemia , elevate serum uric acid ( &gt; 8.0 mg/dl ) Hepatic renal impairment ; elevate serum creatinine ( &gt; 1.4 mg/dl ) Planned vaccination time course study Adherence diet ( i.e , vegetarian ) life style ( incl . extreme sport ) might interfere investigation Laboratory test result outside tolerance value lay study centre , may evidence disease . Positive result HIV1/2 , HCV antibody HBs antigen test Regular use medication within four week prior commencement study ( selfmedication prescription ) Single use medication ( include OTC ) expressively permit within two week prior start study Abuse alcohol , caffeine tobacco ( equivalent 10 cigarette day ) Drug addiction Participation clinical investigation blood donation 250 ml within past eight week blood donation le 250 ml within past 4 week Subjects know suspect comply study directives reliable trustworthy capable understand evaluate information give part formal information policy ( informed consent ) , particular regard risk discomfort would agree expose . precarious financial situation longer weigh possible risk participation unpleasantness may involve .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>